Maypro Industries, Purchase, NY, and Japanese company CALPIS Co., Ltd. have signed an agreement making Maypro the U.S. distributor of AmealPeptide. The patented ingredient from CALPIS is clinically proven to support healthy blood pressure. Derived from enzymatically hydrolyzed casein, AmealPeptide is a naturally- occurring ACE inhibitor, and is the only complete lactotripeptide, containing both the VPP and IPP peptides.

“We are very proud to add AmealPeptideto our select portfolio of proprietary branded ingredients” said Steve Yamada, Maypro’s CEO. “It is an honor for us to represent one of Japan’s leading beverage companies and to offer a product supported by such an extensive body of clinical research.”